What can neutralizing antibodies tell us about the quality of immunity in COVID-19 convalescents and vaccinees?

• Published in: Human vaccines & immunotherapeutics Vol. 19; no. 3; p. 2270310
• Main Authors: Ravlić, Sanda, Kurtović, Tihana, Cvetko Krajinović, Lidija, Hećimović, Ana, Miloš, Marija, Mateljak Lukačević, Sanja, Markotić, Alemka, Halassy, Beata
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 15-12-2023; Taylor & Francis Group
• Subjects: Ad26COVS1; Antibodies, Neutralizing; Antibodies, Viral; BNT162 Vaccine; COVID-19 - prevention & control; COVID-19 convalescents; COVID-19 vaccines; Humans; Immunity, Humoral; Neutralizing antibodies; Pandemics; SARS-CoV-2; Vaccination; wild-type SARS-CoV-2 neutralization assay; COVID-19 vaccines; COVID-19 convalescents; SARS-CoV-2; wild-type SARS-CoV-2 neutralization assay; Neutralizing antibodies
• ISSN: 2164-5515; 2164-554X
• DOI: 10.1080/21645515.2023.2270310

During the SARS-CoV-2 pandemic, the lack of standardized measurements of the immune response after vaccination or recovery from COVID-19 resulted in incomparable results and hindered correlation establishment. Prioritizing reliable and standardized methods to monitor pathogen-specific immunity is crucial, not only during the COVID-19 pandemic but also for future outbreaks. During our study of the humoral immune response, we used a SARS-CoV-2 wild-type neutralization assay, ensuring the measurement of the immune response directed to all SARS-CoV-2 antigens in their proper conformation. A head-to-head comparison of the neutralizing antibody (NAb) responses elicited by four vaccines used in Europe during 2021 (BNT162b2, mRNA-1273, ChAdOx nCoV-19, and Ad26.COV2.S) and their comparison to NAb responses in convalescents showed that while the amount was comparable, NAbs induced by natural infection were of higher quality. Namely, NAbs produced by disease were better activators of the complement system than NAbs induced by vaccination. Furthermore, the contribution of spike protein-specific IgGs to the SARS-CoV-2 neutralization was lower in convalescents compared to vaccinees, indicating that those who recovered from COVID-19 were armed with antibodies of additional specificities and/or classes that contributed to virus neutralization. These findings suggest that a higher stringency of public policy measures targeting individuals who have recovered from COVID-19, in comparison to those who have been vaccinated, may not have been fully justified.